MADISON CAREY: Open Payments
NPI 1194207928 · LITITZ, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,097 in 10 payments from 7 companies in 2025. Trend: 2023 $463 · 2024 $633 · 2025 $1,097
Food & beverage: $1,097
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $363 |
| E.R. Squibb & Sons, L.L.C. | 1 | $126 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Genmab U.S., Inc. | 1 | $125 |
| ADC THERAPEUTICS AMERICA, INC. | 1 | $125 |
| Incyte Corporation | 1 | $125 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $108 |
Products named: TECVAYLI, REBLOZYL, ENHERTU, Epkinly, ZYNLONTA, Monjuvi, RYBREVANT, Nubeqa.
Industry payments across PA — which companies pay providers there.
